Health CanadaGeneral Alert
XELJANZ / XELJANZ XR (tofacitinib) - Risk of Thrombosis
Published: December 2, 2019Recall ID: 48046Category: generalCountry: Canada
Reason for Recall / Hazard
Product safety
Product Description & Identification
XELJANZ / XELJANZ XR (tofacitinib) - Risk of Thrombosis
Additional Source Details
| Field | Value |
|---|---|
| N I D | 48046 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/xeljanz-xeljanz-xr-tofacitinib-risk-thrombosis |
| Issue | Product safety |
| Title | XELJANZ / XELJANZ XR (tofacitinib) - Risk of Thrombosis |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2019-12-02 |
| Organization | Marketed health products |